362 related articles for article (PubMed ID: 12358038)
1. International Conference on Harmonisation; guidance on Q1A stability testing of new drug substances and products; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2001 Nov; 66(216):56332-3. PubMed ID: 12358038
[TBL] [Abstract][Full Text] [Related]
2. International Conference on Harmonisation; evaluation of stability data; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2004 Jun; 69(110):32010-1. PubMed ID: 15185712
[TBL] [Abstract][Full Text] [Related]
3. International Conference on Harmonisation; Stability Data Package for Registration Applications in Climatic Zones III and IV; Stability Testing of New Drug Substances and Products; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2003 Nov; 68(225):65717-8. PubMed ID: 14631936
[TBL] [Abstract][Full Text] [Related]
4. International Conference on Harmonisation: guidance on Q1D bracketing and matrixing designs for stability testing of new drug substances and products; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2003 Jan; 68(11):2339-40. PubMed ID: 12532979
[TBL] [Abstract][Full Text] [Related]
5. International Conference on Harmonisation; revised guidance on Q3B(R) Impurities in New Drug Products; Availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2003 Nov; 68(220):64628-9. PubMed ID: 14619944
[TBL] [Abstract][Full Text] [Related]
6. International Conference on Harmonisation; guidance on E11 clinical investigation of medicinal products in the pediatric population; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2000 Dec; 65(242):78493-4. PubMed ID: 12362934
[TBL] [Abstract][Full Text] [Related]
7. International Conference on Harmonisation; guidance on S7A safety pharmacology studies for human pharmaceuticals; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2001 Jul; 66(135):36791-2. PubMed ID: 12356097
[TBL] [Abstract][Full Text] [Related]
8. International Conference on Harmonisation; revised guidance on Q3A impurities in new drug substances; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2003 Feb; 68(28):6924-5. PubMed ID: 12583358
[TBL] [Abstract][Full Text] [Related]
9. International Conference on Harmonisation; guidance on Q6A specifications: test procedures and acceptance criteria for new drug substances and new drug products: chemical substances. Notice.
Food and Drug Administration, HHS
Fed Regist; 2000 Dec; 65(251):83041-63. PubMed ID: 12356095
[TBL] [Abstract][Full Text] [Related]
10. International Conference on Harmonisation; Guidance on S9 Nonclincal Evaluation for Anticancer Pharmaceuticals; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2010 Mar; 75(44):10487-8. PubMed ID: 20383918
[TBL] [Abstract][Full Text] [Related]
11. International Conference on Harmonisation; guidance on the M4 Common Technical Document--Quality: Questions and Answers/Location Issues; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2004 Jun; 69(111):32358-9. PubMed ID: 15188781
[TBL] [Abstract][Full Text] [Related]
12. International Conference on Harmonisation; guidance on the duration of chronic toxicity testing in animals (rodent and nonrodent toxicity testing); availability. Notice. Food and Drug Administration, HHS.
Fed Regist; 1999 Jun; 64(122):34259-60. PubMed ID: 12356093
[TBL] [Abstract][Full Text] [Related]
13. International Conference on Harmonisation; Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the International Conference on Harmonisation Regions; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2008 Feb; 73(35):9575-6. PubMed ID: 18677819
[TBL] [Abstract][Full Text] [Related]
14. International Conference on Harmonisation; guidance on data elements for transmission of individual case safety reports; availability. Notice. Food and Drug Administration, HHS.
Fed Regist; 1998 Jan; 63(10):2396-404. PubMed ID: 12296373
[TBL] [Abstract][Full Text] [Related]
15. International Conference on Harmonisation; guidance on specifications: test procedures and acceptance criteria for biotechnological/biological products. Notice. Food and Drug Administration, HHS.
Fed Regist; 1999 Aug; 64(159):44928-35. PubMed ID: 12356094
[TBL] [Abstract][Full Text] [Related]
16. International Conference on Harmonisation; choice of control group and related issues in clinical trials; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2001 May; 66(93):24390-1. PubMed ID: 12356096
[TBL] [Abstract][Full Text] [Related]
17. International Conference on Harmonisation; guidance on M4 common technical document; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2001 Oct; 66(200):52634-7. PubMed ID: 12358037
[TBL] [Abstract][Full Text] [Related]
18. International Cooperation on Harmonisation of Technical Requirements for Approval of Veterinary Medicinal Products (VICH); final guidance for industry on "studies to evaluate the safety of residues of veterinary drugs in human food: genotoxicity testing" (VICH GL23); availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2002 Jan; 67(3):602-3. PubMed ID: 12358039
[TBL] [Abstract][Full Text] [Related]
19. International Conference on Harmonisation; guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for use in the International Conference on Harmonisation Regions; Annex 4C on Microbiological Examination of Nonsterile Products: Acceptance Criteria for Pharmaceutical Preparations and Substances for Pharmaceutical Use General Chapter; availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2009 Apr; 74(66):15992-3. PubMed ID: 19507323
[TBL] [Abstract][Full Text] [Related]
20. International Cooperation on Harmonisation of Technical requirements for Approval of Veterinary Medicinal Products (VICH); final guidance on " Safety studies for veterinary drug residues in human food: reproduction toxicity testing" (VICH GL22); availability. Notice.
Food and Drug Administration, HHS
Fed Regist; 2002 Jan; 67(3):603-5. PubMed ID: 12365425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
